Prothena | PRTA - Ativo Circulante

Preço das Ações
10.50
Mudança Diária
-0.08 -0.76%
Mensal
9.60%
Anual
2.74%
Q2 Previsão
10.19




Ativo Circulante Alterar Data
Acadia Pharmaceuticals USD 1.06B 14.31M 2025-12
Agios Pharmaceuticals USD 942.05M 91.06M 2025-12
Akebia Therapeutics USD 252.96M 5.38M 2025-12
ALKERMES USD 1.93B 187.5M 2025-12
Alnylam Pharmaceuticals USD 4.05B 97.85M 2025-12
Amgen USD 29.06B 1.17B 2025-12
Biogen USD 8.97B 37.5M 2025-12
BioMarin Pharmaceutical USD 3.95B 98.95M 2025-12
Exelixis USD 1.44B 41.03M 2025-12
Immunic USD 39.27M 20.57M 2025-09
Incyte USD 5.02B 746.01M 2025-12
Ionis Pharmaceuticals USD 2.99B 471.01M 2025-12
MacroGenics USD 219.94M 12.15M 2025-12
Nektar Therapeutics USD 266.27M 15.09M 2025-12
Neurocrine Biosciences USD 2.52B 364.3M 2025-12
Prothena USD 315.19M 24.78M 2025-12
Regeneron Pharmaceuticals USD 18.02B 41.2M 2025-12
Ultragenyx Pharmaceutical USD 643.21M 76.58M 2025-09
Vertex Pharmaceuticals USD 11.2B 631.4M 2025-12
Xoma USD 110.71M 5.78M 2025-09